Palleiko Benjamin L

CIK 00013662443 companiesFRAMINGHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001366244

Recent Transactions

50 trades

Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-03-09$16.08/sh−6,693→ 451,815 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-03-06+15,625→ 458,508 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-03-06−15,625→ 125,001 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-23$15.57/sh−10,034→ 442,883 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-21+23,250→ 452,917 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-21−23,250→ 279,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-18$15.00/sh−1,038→ 429,667 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-17+2,419→ 430,705 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-17−2,419→ 2,419 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-12$15.70/sh−3,354→ 428,286 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2026-02-11+7,120→ 431,640 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-02-11−7,120→ 99,680 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-01-16+325,000→ 325,000 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-12-08$16.51/sh−7,294→ 424,520 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-12-06−15,625→ 140,626 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-12-06+15,625→ 431,814 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−10,940→ 416,189 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−23,250→ 302,250 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+23,250→ 427,129 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-18$14.48/sh−4,466→ 403,879 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-17+9,364→ 408,345 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-17−6,945→ 0 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-17−2,419→ 4,838 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-12$11.55/sh−3,328→ 398,981 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-11−7,120→ 106,800 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-11+7,120→ 402,309 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-09-08$15.84/sh−7,294→ 395,189 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-09-06+15,625→ 402,483 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-09-06−15,625→ 156,251 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-22$13.22/sh−10,940→ 386,858 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-21+23,250→ 397,798 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-21−23,250→ 325,500 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-18$13.19/sh−4,409→ 374,548 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-08-17+9,362→ 378,957 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-17−2,418→ 7,257 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-17−6,944→ 6,945 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Employee Stock Option
2025-08-11+113,920→ 113,920 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-08-11+113,920→ 113,920 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-07-09$15.69/sh−32,979→ 369,595 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-07-08+87,500→ 402,574 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-06-09$14.50/sh−7,169→ 315,074 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-06-06+15,625→ 322,243 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-06-06−15,625→ 171,876 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-22$11.88/sh−9,999→ 306,618 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-21−23,250→ 348,750 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-21+23,250→ 316,617 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-19$11.84/sh−3,808→ 293,367 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-05-17+9,364→ 297,175 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-17−6,945→ 13,889 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-05-17−2,419→ 9,675 total

Companies

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov